financetom
Business
financetom
/
Business
/
BRIEF-Smiths Detection Announces Acquisition Of Med Graphix Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Smiths Detection Announces Acquisition Of Med Graphix Inc.
Aug 5, 2025 6:14 AM

Aug 5 (Reuters) - Smiths Group PLC ( SMGKF ):

* SMITHS DETECTION ANNOUNCES ACQUISITION OF MED GRAPHIX INC.

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RTX's GPS Ground Control System Facing Hurdles Ahead of October Delivery, GAO Says
RTX's GPS Ground Control System Facing Hurdles Ahead of October Delivery, GAO Says
Sep 9, 2024
11:30 AM EDT, 09/09/2024 (MT Newswires) -- RTX (RTX) must meet additional criteria if it is to successfully deliver its ground network to control GPS satellites by the October target date, the Government Accountability Office said in a report Monday. The Department of Defense has worked for over two decades to modernize its GPS with a jam-resistant, more secure, military-specific...
Planet Labs Unit Selected for Multiple Award NASA Contract
Planet Labs Unit Selected for Multiple Award NASA Contract
Sep 9, 2024
10:43 AM EDT, 09/09/2024 (MT Newswires) -- Planet Labs (PL) said Monday that its Planet Federal subsidiary was selected for the NASA Commercial SmallSat Data Acquisition Program On-Ramp1 multiple award contract, which has a maximum potential value of $476 million for all contractors selected. The fixed-price, indefinite-delivery/indefinite-quantity contract extends through Nov. 15, 2028 and will cover services to provide commercial...
Replimune Plans to Submit Biologics License Application for RP1 in H2 After 'Successful' Pre-BLA Meeting
Replimune Plans to Submit Biologics License Application for RP1 in H2 After 'Successful' Pre-BLA Meeting
Sep 9, 2024
11:04 AM EDT, 09/09/2024 (MT Newswires) -- Replimune Group ( REPL ) said Monday it is planning to submit a Biologics License Application for RP1 to the US Food and Drug Administration via the accelerated approval pathway in H2 after a successful pre-BLA meeting with the drug regulator. RP1 is the company's lead product candidate to treat anti-PD1 failed melanoma,...
Update: Summit Therapeutics' Trial Shows Ivonescimab Significantly Improved Progression-Free Survival, Shares Rise
Update: Summit Therapeutics' Trial Shows Ivonescimab Significantly Improved Progression-Free Survival, Shares Rise
Sep 9, 2024
11:19 AM EDT, 09/09/2024 (MT Newswires) -- (Updates with the latest stock movement in the first paragraph.) Summit Therapeutics ( SMMT ) shares were up 60% in recent Monday trading after the company said Sunday its phase 3 trial for non-small cell lung cancer treatment showed improved survival rate compared with pembrolizumab monotherapy. The company said Sunday that data from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved